MAPT and neurodegenerative disease: The detailed understanding of the performance of Tau antibody reagents presented here will improve interpretation of research data, enhance reproducibility of future Tau research studies, and guide the choice of appropriate antibodies for different research questions and sample types, ultimately enabling faster progress towards understanding the many neurodegenerative diseases where the protein has been implicated.